Publication date: Available online 18 November 2026 Source: The Lancet Infectious Diseases Author(s): Simon Feys, Rosanne Sprute, Sarah Dellière, Dimitrios Kontoyiannis, Katrien Lagrou, Bart J A Rijnders, Isabel Spriet, George R Thompson, Frank L van de Veerdonk, Martin Hoenigl, Johan Maertens, Joost Wauters
Improving the treatment of invasive fungal infections: novel antifungal and host-directed therapies. // The Lancet Infectious Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1473309926005220?dgcid=rss_sd_all
Improving the treatment of invasive fungal infections: novel antifungal and host-directed therapies. The Lancet Infectious Diseases. https://www.sciencedirect.com/science/article/pii/S1473309926005220?dgcid=rss_sd_all
“Improving the treatment of invasive fungal infections: novel antifungal and host-directed therapies.” The Lancet Infectious Diseases.
@article{article108820,
title = {Improving the treatment of invasive fungal infections: novel antifungal and host-directed therapies},
journal = {The Lancet Infectious Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1473309926005220?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...